1. Yao, Y. et al. A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity. eLife 4, e05449 (2015).

2. Komatsu, H. et al. Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders. PLoS ONE 9, e90134 (2014).

3. Martin, A. L., Steurer, M. A. & Aronstam, R. S. Constitutive activity among orphan class-A G protein coupled receptors. PLoS ONE 10, e0138463 (2015).

4. Foster, S. R. et al. Discovery of human signaling systems: pairing peptides to G protein-coupled receptors. Cell 179, 895–908 (2019).

5. Krutzke, S. K. et al. Array-based molecular karyotyping in fetal brain malformations: identification of novel candidate genes and chromosomal regions. Birth Defects Res. A Clin. Mol. Teratol. 106, 16–26 (2016).

6. Setoh, M. et al. Discovery of the first potent and orally available agonist of the orphan G-protein-coupled receptor 52. J. Med. Chem. 57, 5226–5237 (2014).

7. Nishiyama, K. et al. FTBMT, a novel and selective GPR52 agonist, demonstrates antipsychotic-like and procognitive effects in rodents, revealing a potential therapeutic agent for schizophrenia. J. Pharmacol. Exp. Ther. 363, 253–264 (2017).

8. Komatsu, H. Novel therapeutic GPCRs for psychiatric disorders. Int. J. Mol. Sci. 16, 14109–14121 (2015).

9. Alavi, M. S., Shamsizadeh, A., Azhdari-Zarmehri, H. & Roohbakhsh, A. Orphan G protein-coupled receptors: the role in CNS disorders. Biomed Pharmacother. 98, 222–232 (2018).

10. Song, H. et al. Targeting Gpr52 lowers mutant HTT levels and rescues Huntington’s disease-associated phenotypes. Brain 141, 1782–1798 (2018).

11. Rasmussen, S. G. et al. Crystal structure of the β 2 adrenergic receptor–Gs protein complex. Nature 477, 549–555 (2011).

12. García-Nafría, J., Lee, Y., Bai, X., Carpenter, B. & Tate, C. G. Cryo-EM structure of the adenosine A 2A receptor coupled to an engineered heterotrimeric G protein. eLife 7, e35946 (2018).

13. Liang, Y. L. et al. Phase-plate cryo-EM structure of a class B GPCR–G-protein complex. Nature 546, 118–123 (2017).

14. Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248–253 (2017).

15. Liang, Y. L. et al. Cryo-EM structure of the active, G s -protein complexed, human CGRP receptor. Nature 561, 492–497 (2018).

16. Zhao, L. H. et al. Structure and dynamics of the active human parathyroid hormone receptor-1. Science 364, 148–153 (2019).

17. Rauser, L., Savage, J. E., Meltzer, H. Y. & Roth, B. L. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine 2C receptor. J. Pharmacol. Exp. Ther. 299, 83–89 (2001).

18. Katritch, V. et al. Allosteric sodium in class A GPCR signaling. Trends Biochem. Sci. 39, 233–244 (2014).

19. Venkatakrishnan, A. J. et al. Molecular signatures of G-protein-coupled receptors. Nature 494, 185–194 (2013).

20. Ma, Y. et al. Structural basis for apelin control of the human apelin receptor. Structure 25, 858–866 (2017).

21. Wacker, D. et al. Crystal structure of an LSD-bound human serotonin receptor. Cell 168, 377–389 (2017).

22. Ballesteros, J. A. & Weinstein, H. in Receptor Molecular Biology, Methods in Neurosciences vol. 25 (ed. Sealfon, S. C.) 366–428 (Elsevier, 1995).

23. Wang, S. & Wacker, D. D 4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358, 381–386 (2017).

24. Carpenter, B. & Tate, C. G. Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation. Protein Eng. Des. Sel. 29, 583–594 (2016).

25. Nakahata, T. et al. Design and synthesis of 1-(1-benzothiophen-7-yl)-1H-pyrazole, a novel series of G protein-coupled receptor 52 (GPR52) agonists. Bioorg. Med. Chem. 26, 1598–1608 (2018).

26. García-Nafría, J., Nehmé, R., Edwards, P. C. & Tate, C. G. Cryo-EM structure of the serotonin 5-HT 1B receptor coupled to heterotrimeric G o . Nature 558, 620–623 (2018).

27. Kang, Y. et al. Cryo-EM structure of human rhodopsin bound to an inhibitory G protein. Nature 558, 553–558 (2018).

28. Koehl, A. et al. Structure of the µ-opioid receptor–G i protein complex. Nature 558, 547–552 (2018).

29. Maeda, S., Qu, Q., Robertson, M. J., Skiniotis, G. & Kobilka, B. K. Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes. Science 364, 552–557 (2019).

30. Qi, X. et al. Cryo-EM structure of oxysterol-bound human Smoothened coupled to a heterotrimeric G i . Nature 571, 279–283 (2019).

31. Draper-Joyce, C. J. et al. Structure of the adenosine-bound human adenosine A 1 receptor–G i complex. Nature 558, 559–563 (2018).

32. Kato, H. E. et al. Conformational transitions of a neurotensin receptor 1–G i1 complex. Nature 572, 80–85 (2019).

33. Ballesteros, J. A. et al. Activation of the β 2 -adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276, 29171–29177 (2001).

34. Greasley, P. J., Fanelli, F., Rossier, O., Abuin, L. & Cotecchia, S. Mutagenesis and modelling of the α 1b -adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol. Pharmacol. 61, 1025–1032 (2002).

35. Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K. & Roth, B. L. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277, 11441–11449 (2002).

36. Romo, T. D., Grossfield, A. & Pitman, M. C. Concerted interconversion between ionic lock substates of the β 2 adrenergic receptor revealed by microsecond timescale molecular dynamics. Biophys. J. 98, 76–84 (2010).

37. Wang, S. et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555, 269–273 (2018).

38. Munk, C. et al. An online resource for GPCR structure determination and analysis. Nat. Methods 16, 151–162 (2019).

39. Audet, M. & Stevens, R. C. Emerging structural biology of lipid G protein-coupled receptors. Protein Sci. 28, 292–304 (2019).

40. Kakarala, K. K. & Jamil, K. Sequence-structure based phylogeny of GPCR class A rhodopsin receptors. Mol. Phylogenet. Evol. 74, 66–96 (2014).

41. Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967–976 (2012).

42. Roth, C. B., Hanson, M. A. & Stevens, R. C. Stabilization of the human β 2 -adrenergic receptor TM4–TM3–TM5 helix interface by mutagenesis of Glu1223.41, a critical residue in GPCR structure. J. Mol. Biol. 376, 1305–1319 (2008).

43. Lv, X. et al. In vitro expression and analysis of the 826 human G protein-coupled receptors. Protein Cell 7, 325–337 (2016).

44. Cherezov, V. et al. Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 µm size X-ray synchrotron beam. J. R. Soc. Interface 6, S587–S597 (2009).

45. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).

46. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).

47. Koehler Leman, J., Mueller, B. K. & Gray, J. J. Expanding the toolkit for membrane protein modeling in Rosetta. Bioinformatics 33, 754–756 (2017).

48. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).

49. Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D 67, 355–367 (2011).

50. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).

51. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).

52. Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).

53. Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).

54. Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).

55. Cardone, G., Heymann, J. B. & Steven, A. C. One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. J. Struct. Biol. 184, 226–236 (2013).

56. Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).

57. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004).

58. Zhang, S. et al. Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder. Proc. Natl Acad. Sci. USA 111, 14571–14576 (2014).

59. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).

60. Yuan, Y., Pei, J. & Lai, L. LigBuilder 2: a practical de novo drug design approach. J. Chem. Inf. Model. 51, 1083–1091 (2011).

61. Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–W324 (2014).